How Much Does Provigil (Modafinil) Cost in New Jersey in 2026?

Brand vs. Generic Modafinil Pricing in New Jersey

Brand-name Provigil, manufactured by Cephalon (now a Teva subsidiary), carries a wholesale acquisition cost near $850 per month for a 30-day supply of 200 mg tablets. Almost no one pays that figure out of pocket. Generic modafinil, available since Cephalon's patent exclusivity ended in 2012, dropped the effective price dramatically.

Across New Jersey retail chains, the average cash-pay price for 30 tablets of generic modafinil 200 mg sits around $80 in 2026. Prices vary by pharmacy. Costco, certain independent pharmacies, and mail-order outlets in the state sometimes list prices between $60 and $95 for the same quantity. Walmart and CVS locations in northern New Jersey tend to cluster near the $75 to $90 range. A single 100 mg tablet, used by patients on half-dose protocols, runs about 40% to 50% less per month.

Pricing at any given New Jersey pharmacy depends on which generic manufacturer the store stocks. Teva, Mylan, Aurobindo, and Sun Pharma all produce modafinil tablets approved under FDA Abbreviated New Drug Applications. Pharmacies negotiate different acquisition costs with wholesalers, and those differences pass through to the consumer.

If you pay cash, always ask the pharmacist to run a price check on multiple manufacturer NDCs before filling. This takes about 90 seconds and can save $15 to $25 per fill.

New Jersey Medicaid Coverage for Modafinil

New Jersey Medicaid covers modafinil, but the program requires prior authorization (PA) before approving the prescription. The PA process exists because modafinil is a Schedule IV controlled substance and the state's Medicaid Preferred Drug List limits open access to certain wakefulness-promoting agents.

To obtain PA approval, the prescribing clinician must document one of the following diagnoses: narcolepsy, obstructive sleep apnea with residual excessive sleepiness despite CPAP therapy, or shift work sleep disorder. The original US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) published in Annals of Neurology in 1998 established the efficacy data that led to FDA approval for narcolepsy, showing that modafinil 200 mg and 400 mg significantly reduced daytime sleepiness on the Maintenance of Wakefulness Test compared to placebo. New Jersey Medicaid formulary reviewers rely on this evidence base.

PA turnaround in New Jersey typically takes 24 to 72 hours for electronic submissions through the state's point-of-sale system. Paper fax submissions may take up to five business days. If the initial request is denied, the prescriber can file a fair hearing appeal through the NJ Division of Medical Assistance and Health Services.

For NJ FamilyCare (the state's expanded Medicaid program), the same PA requirements apply. Enrollees pay no copay for generic modafinil once PA is granted. Brand Provigil requires a non-preferred brand override, which NJ Medicaid rarely approves unless the patient documents therapeutic failure or intolerance to two generic manufacturers.

Insurance Coverage Across NJ Commercial Plans

Most commercial insurance plans sold in New Jersey place generic modafinil on Tier 2 (preferred generic) or Tier 3 (non-preferred generic) of their formularies. Copays at Tier 2 typically range from $15 to $35 per 30-day fill. At Tier 3, expect $40 to $60.

Horizon Blue Cross Blue Shield of New Jersey, the state's largest insurer by enrollment, lists generic modafinil as a Tier 2 drug with PA required for new starts. AmeriHealth New Jersey and Aetna plans sold on the NJ marketplace generally follow similar tiering. Oscar Health, which expanded its NJ footprint in 2025, places modafinil at Tier 2 with step therapy: the plan requires documentation that the patient tried and failed or cannot tolerate a lower-cost alternative before covering modafinil.

Brand Provigil, if specifically requested, lands on Tier 4 (non-preferred brand) or the specialty tier for most NJ plans, with copays exceeding $150 per month. From a clinical standpoint, the FDA's Orange Book confirms therapeutic equivalence between approved generic modafinil products and the Provigil reference listed drug, meaning the generic contains the same active ingredient at the same dose in the same dosage form with the same route of administration.

Here is a practical step: before your first fill, call the number on the back of your insurance card and ask the pharmacy benefits team two questions. First, is modafinil on formulary, and at what tier? Second, does the plan require PA or step therapy? Having these answers before the prescriber writes the script saves a wasted trip to the pharmacy.

How Telehealth Prescribing Works in New Jersey

New Jersey permits telehealth prescribing of Schedule IV controlled substances, including modafinil, under regulations codified after the state's COVID-era telehealth expansion was made permanent. A provider licensed in New Jersey can evaluate a patient via synchronous audio-video visit, establish a patient-provider relationship, and transmit a modafinil prescription electronically to any NJ pharmacy.

The prescriber must use the New Jersey Prescription Monitoring Program (NJ PMP) database to check the patient's controlled substance history before issuing a new modafinil prescription. This check is mandatory under state law for all Schedule II through IV prescriptions.

Telehealth visits for modafinil typically cost $75 to $150 for an initial evaluation, depending on the platform. Follow-up visits for refills run $50 to $100. Some NJ-based telehealth platforms bundle the visit fee with a 90-day prescription and pharmacy coordination, reducing per-month costs.

One constraint: New Jersey requires that the prescribing provider hold an active NJ medical license or be registered through the state's telehealth reciprocity provisions. Out-of-state providers without NJ credentials cannot legally prescribe controlled substances to NJ residents, even for established patients.

Compounded Modafinil in New Jersey

Compounded modafinil is available through 503A-licensed compounding pharmacies operating in New Jersey. Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications based on individual patient prescriptions when a commercial product does not meet a patient's specific clinical need.

Valid reasons for compounding modafinil include allergy to an inactive ingredient in the commercial tablet, need for a non-standard dose (such as 50 mg or 75 mg), or difficulty swallowing tablets where a liquid suspension is medically necessary. "I want it cheaper" is not a legally sufficient reason for a 503A compound, and the New Jersey Board of Pharmacy enforces this distinction.

Pricing for compounded modafinil varies widely. Some 503A pharmacies in New Jersey price compounded modafinil capsules or suspensions between $40 and $120 for a 30-day supply, depending on the dose and formulation. The cost depends on the pharmacy's raw material sourcing and compounding overhead.

A 2018 review in the American Journal of Health-System Pharmacy noted that compounded controlled substances must meet the same state-level prescription requirements as their commercial equivalents. In New Jersey, this means a valid prescription from an NJ-licensed prescriber, PMP check, and proper DEA documentation for Schedule IV handling.

Discount Programs and Savings Strategies

Several paths exist to reduce out-of-pocket modafinil costs in New Jersey.

Manufacturer savings cards. Teva, which markets both brand Provigil and its own authorized generic, periodically offers copay assistance cards. These typically reduce commercial insurance copays by $25 to $75 per fill. The cards do not apply to government insurance (Medicaid, Medicare Part D, Tricare). Check Teva's patient assistance portal directly, as card availability and terms change quarterly.

GoodRx, RxSaver, and similar discount aggregators. These platforms negotiate group discount rates with NJ pharmacies. In May 2026, GoodRx-listed prices for generic modafinil 200 mg (30 tablets) at New Jersey pharmacies range from approximately $55 to $90, depending on the specific location. These prices apply to uninsured or underinsured patients and cannot be combined with insurance copays.

90-day fills. If your prescriber writes a 90-day supply and your insurance or pharmacy supports it, per-tablet costs drop. A 90-day fill of generic modafinil at a mail-order pharmacy affiliated with major NJ insurers typically runs $180 to $220, compared to $240 or more for three separate 30-day fills.

Patient assistance programs. Teva's patient assistance program provides free brand Provigil to uninsured patients with household incomes below 200% of the federal poverty level. The application requires income documentation and a prescriber signature. Approval typically takes two to four weeks.

Pill splitting. Modafinil 200 mg tablets are scored. Patients prescribed 100 mg daily can purchase 200 mg tablets and split them, effectively halving the monthly cost. The FDA permits tablet splitting for scored tablets when done with a proper pill cutter, though patients should confirm this approach with their prescriber.

How Modafinil Compares to Other Wakefulness Agents on Cost

Modafinil is not the only option for excessive daytime sleepiness, and NJ patients sometimes switch between agents based on price, insurance coverage, or side effect profiles.

Armodafinil (Nuvigil), the R-enantiomer of modafinil, has a similar generic cash price in New Jersey: roughly $80 to $100 per month. Some NJ insurance plans prefer armodafinil over modafinil on formulary, or vice versa, which can shift copay costs by $10 to $20 per fill.

Solriamfetol (Sunosi), approved by the FDA in 2019 for narcolepsy and OSA-related sleepiness, remains brand-only. NJ cash prices exceed $500 per month. Insurance coverage requires extensive PA documentation, and many NJ Medicaid plans do not cover it.

Pitolisant (Wakix), approved for narcolepsy with or without cataplexy, carries NJ cash prices above $8,000 per month. A randomized controlled trial published in The Lancet Neurology (N=261) demonstrated pitolisant's efficacy against placebo on the Epworth Sleepiness Scale, but its cost profile makes it a last-line option for most NJ patients. Insurance approval typically requires documented failure of modafinil and armodafinil.

Generic modafinil remains the lowest-cost wakefulness agent available in New Jersey. As Dr. Thomas Scammell of Harvard Medical School's Division of Sleep Medicine has noted: "For most patients with narcolepsy or residual sleepiness in OSA, modafinil remains a reasonable first-line choice given its efficacy profile and cost advantages over newer agents."

The American Academy of Sleep Medicine's 2021 clinical practice guideline for the treatment of central disorders of hypersomnolence rated modafinil as a strong recommendation for narcolepsy type 2 and a conditional recommendation for narcolepsy type 1, stating: "Modafinil/armodafinil should be used for the treatment of daytime sleepiness in adults with narcolepsy."

Tips for Getting the Lowest Price in New Jersey

Start with insurance. If you have commercial coverage, check formulary placement and PA requirements before the prescription is written. Have your prescriber submit PA electronically for fastest turnaround.

If uninsured, compare prices at three or more NJ pharmacies. Costco's pharmacy is open to non-members in New Jersey (state law requires it). Independent pharmacies in Newark, Jersey City, and Trenton sometimes undercut chain pricing by 10% to 20%.

Stack savings where allowed. A manufacturer copay card can sometimes be applied on top of insurance. Discount card prices from GoodRx or RxSaver replace insurance pricing entirely, so use whichever is lower.

Request 90-day fills once your dose is stable. This reduces both per-unit cost and the number of pharmacy visits.

Ask about therapeutic alternatives. If your NJ plan prefers armodafinil and places it at a lower copay tier, and your clinician agrees the switch is appropriate, the cost difference may justify the change.

For NJ Medicaid enrollees, the generic is covered at zero copay once PA is approved. There is no reason to pay out of pocket if you qualify for NJ FamilyCare.